Q2 2024 Holdings
Filed 2024-08-14 | 24 holdings | $326.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CG Oncology Inc(CGON) | COM | 156944100 | $172.3M | 5,458,810 | 52.8% |
| Nuvation Bio Inc.(NUVB) | COM | 67080N101 | $20.3M | 6,950,239 | 6.2% |
| Arcus Biosciences, Inc(RCUS) | COM | 03969F109 | $13.2M | 869,790 | 4.1% |
| Zentalis Pharmaceuticals Inc.(ZNTL) | COM | 98943L107 | $12.6M | 3,070,442 | 3.8% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $12.1M | 65,772 | 3.7% |
| BeyondSpring Inc.(BYSI) | SHS | G10830100 | $11.9M | 4,958,143 | 3.6% |
| Illumnia, Inc.(ILMN) | COM | 452327109 | $11.4M | 108,767 | 3.5% |
| Merus NV | COM | N5749R100 | $10.6M | 179,098 | 3.2% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $8.8M | 850,000 | 2.7% |
| Newamsterdam Pharma Co NV(NAMS) | COM | N62509109 | $7.7M | 400,000 | 2.4% |
| Moonlake Immunotherapeutics | COM | G4444C102 | $7.3M | 166,600 | 2.2% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $7.3M | 347,835 | 2.2% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $7.1M | 157,958 | 2.2% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $5.1M | 94,043 | 1.6% |
| Legend Biotech Corp(LEGN) | ADR | 52490G102 | $4.4M | 98,558 | 1.3% |
| Aura Biosciences, Inc.(AURA) | COM | 05153U107 | $3.9M | 515,555 | 1.2% |
| Equillium Inc.(EQ) | COM | 29446K106 | $3.1M | 4,447,308 | 0.9% |
| GeneDx Holdings Corp.(WGS) | COM CL A | 81663L200 | $2.7M | 103,604 | 0.8% |
| Vera Therapeutics Inc(VERA) | COM | 92337R101 | $2.5M | 69,767 | 0.8% |
| Pyxis Oncology, Inc (formerly Apexigen)(PYXS) | COM | 747324101 | $1.1M | 326,810 | 0.3% |
| AtriCure Inc.(ATRC) | COM | 04963C209 | $610.2K | 26,797 | 0.2% |
| Grail Inc(GRAL) | COM | 384747101 | $278.6K | 18,127 | 0.1% |
| Nuvation Bio Inc.(NUVB/WS) | WARRANTS | 67080N119 | $103.4K | 646,057 | 0.0% |
| Arcellx Inc(ACLX) | COM | 03940C100 | $65.0K | 1,177 | 0.0% |